BioNexus Gene Lab (BGLC) said it is partnering with ML Tech to optimize its Ethereum-focused treasury strategy.
The company said it plans to leverage ML Tech's digital asset trading infrastructure to grow its Ethereum holdings. ML Tech is a wealth management platform for digital assets.
Shares of the company were up over 3% in recent trading.
Price: 0.36, Change: +0.01, Percent Change: +3.77
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。